APO Research
Talk to an analyst

APO RESEARCH · REPORT

Opioid Receptor Agonist

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Opioid Receptor Agonist Industry Growth and Trends Forecast to 2032

29 December 2025110 pages

Choose your research edition.

Industry ResearchOpioid Receptor Agonist Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal Opioid Receptor Agonist Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Opioid Receptor Agonist Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Opioid Receptor Agonist Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Opioid Receptor Agonist Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Opioid Receptor Agonist market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Opioid Receptor Agonist is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Opioid Receptor Agonist is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Opioid Receptor Agonist is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Opioid Receptor Agonist include Allergan, DAIICHI SANKYO COMPANY, Endo Pharmaceuticals, Fresenius Kabi, Hikma Pharmaceuticals, Indivior, Mylan N.V., Piramal Critical Care and Purdue Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Opioid Receptor Agonist market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Opioid Receptor Agonist market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Opioid Receptor Agonist market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Opioid Receptor Agonist.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Opioid Receptor Agonist market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Opioid Receptor Agonist Market by Company

Allergan

DAIICHI SANKYO COMPANY

Endo Pharmaceuticals

Fresenius Kabi

Hikma Pharmaceuticals

Indivior

Mylan N.V.

Piramal Critical Care

Purdue Pharma

Sun Pharmaceutical Industries

Tris Pharma

US WorldMeds

Pfizer

Johnson & Johnson

Teva Pharmaceutical Industries

Opioid Receptor Agonist Segment by Type

Morphine

Codeine

Fentanyl

Others

Opioid Receptor Agonist Segment by Application

Retail Pharmacy

Online Pharmacy

Hospital Pharmacy

Opioid Receptor Agonist Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Opioid Receptor Agonist market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Opioid Receptor Agonist and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Opioid Receptor Agonist.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Opioid Receptor Agonist manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Opioid Receptor Agonist in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Morphine Table 2. Major Company of Codeine Table 3. Major Company of Fentanyl Table 4. Major Company of Others Table 5. Global Opioid Receptor Agonist Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Opioid Receptor Agonist Sales by Type (2021-2026) & (K Units) Table 7. Global Opioid Receptor Agonist Sales Market Share in Volume by Type (2021-2026) Table 8. Global Opioid Receptor Agonist Sales by Type (2021-2026) & (US$ Million) Table 9. Global Opioid Receptor Agonist Sales Market Share in Value by Type (2021-2026) Table 10. Global Opioid Receptor Agonist Price by Type (2021-2026) & (US$/Unit) Table 11. Global Opioid Receptor Agonist Sales by Type (2027-2032) & (K Units) Table 12. Global Opioid Receptor Agonist Sales Market Share in Volume by Type (2027-2032) Table 13. Global Opioid Receptor Agonist Sales by Type (2027-2032) & (US$ Million) Table 14. Global Opioid Receptor Agonist Sales Market Share in Value by Type (2027-2032) Table 15. Global Opioid Receptor Agonist Price by Type (2027-2032) & (US$/Unit) Table 16. North America Opioid Receptor Agonist Sales by Type (2021-2026) & (K Units) Table 17. North America Opioid Receptor Agonist Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Opioid Receptor Agonist Sales by Type (2021-2026) & (K Units) Table 19. Europe Opioid Receptor Agonist Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Opioid Receptor Agonist Sales by Type (2021-2026) & (K Units) Table 21. Asia-Pacific Opioid Receptor Agonist Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Opioid Receptor Agonist Sales by Type (2021-2026) & (K Units) Table 23. Latin America Opioid Receptor Agonist Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Opioid Receptor Agonist Sales by Type (2021-2026) & (K Units) Table 25. Middle East and Africa Opioid Receptor Agonist Sales by Type (2021-2026) & (US$ Million) Table 26. Opioid Receptor Agonist Industry Trends Table 27. Opioid Receptor Agonist Industry Drivers Table 28. Opioid Receptor Agonist Industry Opportunities and Challenges Table 29. Opioid Receptor Agonist Industry Restraints Table 30. Global Opioid Receptor Agonist Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Opioid Receptor Agonist Revenue Market Share by Company (2021-2026) Table 32. Global Opioid Receptor Agonist Sales by Company (2021-2026) & (K Units) Table 33. Global Opioid Receptor Agonist Sales Share by Company (2021-2026) Table 34. Global Opioid Receptor Agonist Market Price by Company (2021-2026) & (US$/Unit) Table 35. Global Opioid Receptor Agonist Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Opioid Receptor Agonist Major Company Production Sites and Headquarters Table 37. Global Opioid Receptor Agonist Company, Product Type & Application Table 38. Global Opioid Receptor Agonist Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Opioid Receptor Agonist by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Opioid Receptor Agonist Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Opioid Receptor Agonist Sales by Region (2021-2026) & (K Units) Table 43. Global Opioid Receptor Agonist Sales Market Share in Volume by Region (2021-2026) Table 44. Global Opioid Receptor Agonist Sales by Region (2021-2026) & (US$ Million) Table 45. Global Opioid Receptor Agonist Sales Market Share in Value by Region (2021-2026) Table 46. Global Opioid Receptor Agonist Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 47. Global Opioid Receptor Agonist Sales by Region (2027-2032) & (K Units) Table 48. Global Opioid Receptor Agonist Sales Market Share in Volume by Region (2027-2032) Table 49. Global Opioid Receptor Agonist Sales by Region (2027-2032) & (US$ Million) Table 50. Global Opioid Receptor Agonist Sales Market Share in Value by Region (2027-2032) Table 51. Global Opioid Receptor Agonist Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 52. Global Opioid Receptor Agonist Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Opioid Receptor Agonist Sales by Application (2021-2026) & (K Units) Table 54. Global Opioid Receptor Agonist Sales Market Share in Volume by Application (2021-2026) Table 55. Global Opioid Receptor Agonist Sales by Application (2021-2026) & (US$ Million) Table 56. Global Opioid Receptor Agonist Sales Market Share in Value by Application (2021-2026) Table 57. Global Opioid Receptor Agonist Price by Application (2021-2026) & (US$/Unit) Table 58. Global Opioid Receptor Agonist Sales by Application (2027-2032) & (K Units) Table 59. Global Opioid Receptor Agonist Sales Market Share in Volume by Application (2027-2032) Table 60. Global Opioid Receptor Agonist Sales by Application (2027-2032) & (US$ Million) Table 61. Global Opioid Receptor Agonist Sales Market Share in Value by Application (2027-2032) Table 62. Global Opioid Receptor Agonist Price by Application (2027-2032) & (US$/Unit) Table 63. North America Opioid Receptor Agonist Sales by Application (2021-2026) & (K Units) Table 64. North America Opioid Receptor Agonist Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Opioid Receptor Agonist Sales by Application (2021-2026) & (K Units) Table 66. Europe Opioid Receptor Agonist Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Opioid Receptor Agonist Sales by Application (2021-2026) & (K Units) Table 68. Asia-Pacific Opioid Receptor Agonist Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Opioid Receptor Agonist Sales by Application (2021-2026) & (K Units) Table 70. Latin America Opioid Receptor Agonist Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Opioid Receptor Agonist Sales by Application (2021-2026) & (K Units) Table 72. Middle East and Africa Opioid Receptor Agonist Sales by Application (2021-2026) & (US$ Million) Table 73. Allergan Company Information Table 74. Allergan Business Overview Table 75. Allergan Opioid Receptor Agonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Allergan Opioid Receptor Agonist Product Portfolio Table 77. Allergan Recent Development Table 78. DAIICHI SANKYO COMPANY Company Information Table 79. DAIICHI SANKYO COMPANY Business Overview Table 80. DAIICHI SANKYO COMPANY Opioid Receptor Agonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. DAIICHI SANKYO COMPANY Opioid Receptor Agonist Product Portfolio Table 82. DAIICHI SANKYO COMPANY Recent Development Table 83. Endo Pharmaceuticals Company Information Table 84. Endo Pharmaceuticals Business Overview Table 85. Endo Pharmaceuticals Opioid Receptor Agonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Endo Pharmaceuticals Opioid Receptor Agonist Product Portfolio Table 87. Endo Pharmaceuticals Recent Development Table 88. Fresenius Kabi Company Information Table 89. Fresenius Kabi Business Overview Table 90. Fresenius Kabi Opioid Receptor Agonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Fresenius Kabi Opioid Receptor Agonist Product Portfolio Table 92. Fresenius Kabi Recent Development Table 93. Hikma Pharmaceuticals Company Information Table 94. Hikma Pharmaceuticals Business Overview Table 95. Hikma Pharmaceuticals Opioid Receptor Agonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Hikma Pharmaceuticals Opioid Receptor Agonist Product Portfolio Table 97. Hikma Pharmaceuticals Recent Development Table 98. Indivior Company Information Table 99. Indivior Business Overview Table 100. Indivior Opioid Receptor Agonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Indivior Opioid Receptor Agonist Product Portfolio Table 102. Indivior Recent Development Table 103. Mylan N.V. Company Information Table 104. Mylan N.V. Business Overview Table 105. Mylan N.V. Opioid Receptor Agonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Mylan N.V. Opioid Receptor Agonist Product Portfolio Table 107. Mylan N.V. Recent Development Table 108. Piramal Critical Care Company Information Table 109. Piramal Critical Care Business Overview Table 110. Piramal Critical Care Opioid Receptor Agonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Piramal Critical Care Opioid Receptor Agonist Product Portfolio Table 112. Piramal Critical Care Recent Development Table 113. Purdue Pharma Company Information Table 114. Purdue Pharma Business Overview Table 115. Purdue Pharma Opioid Receptor Agonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Purdue Pharma Opioid Receptor Agonist Product Portfolio Table 117. Purdue Pharma Recent Development Table 118. Sun Pharmaceutical Industries Company Information Table 119. Sun Pharmaceutical Industries Business Overview Table 120. Sun Pharmaceutical Industries Opioid Receptor Agonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. Sun Pharmaceutical Industries Opioid Receptor Agonist Product Portfolio Table 122. Sun Pharmaceutical Industries Recent Development Table 123. Tris Pharma Company Information Table 124. Tris Pharma Business Overview Table 125. Tris Pharma Opioid Receptor Agonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 126. Tris Pharma Opioid Receptor Agonist Product Portfolio Table 127. Tris Pharma Recent Development Table 128. US WorldMeds Company Information Table 129. US WorldMeds Business Overview Table 130. US WorldMeds Opioid Receptor Agonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 131. US WorldMeds Opioid Receptor Agonist Product Portfolio Table 132. US WorldMeds Recent Development Table 133. Pfizer Company Information Table 134. Pfizer Business Overview Table 135. Pfizer Opioid Receptor Agonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 136. Pfizer Opioid Receptor Agonist Product Portfolio Table 137. Pfizer Recent Development Table 138. Johnson & Johnson Company Information Table 139. Johnson & Johnson Business Overview Table 140. Johnson & Johnson Opioid Receptor Agonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 141. Johnson & Johnson Opioid Receptor Agonist Product Portfolio Table 142. Johnson & Johnson Recent Development Table 143. Teva Pharmaceutical Industries Company Information Table 144. Teva Pharmaceutical Industries Business Overview Table 145. Teva Pharmaceutical Industries Opioid Receptor Agonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 146. Teva Pharmaceutical Industries Opioid Receptor Agonist Product Portfolio Table 147. Teva Pharmaceutical Industries Recent Development Table 148. North America Opioid Receptor Agonist Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 149. North America Opioid Receptor Agonist Sales by Country (2021-2026) & (K Units) Table 150. North America Opioid Receptor Agonist Sales Market Share by Country (2021-2026) Table 151. North America Opioid Receptor Agonist Sales Forecast by Country (2027-2032) & (K Units) Table 152. North America Opioid Receptor Agonist Sales Market Share Forecast by Country (2027-2032) Table 153. North America Opioid Receptor Agonist Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. North America Opioid Receptor Agonist Market Size by Country (2021-2026) & (US$ Million) Table 155. North America Opioid Receptor Agonist Market Share by Country (2021-2026) Table 156. North America Opioid Receptor Agonist Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. North America Opioid Receptor Agonist Market Share Forecast by Country (2027-2032) Table 158. Europe Opioid Receptor Agonist Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 159. Europe Opioid Receptor Agonist Sales by Country (2021-2026) & (K Units) Table 160. Europe Opioid Receptor Agonist Sales Market Share by Country (2021-2026) Table 161. Europe Opioid Receptor Agonist Sales Forecast by Country (2027-2032) & (K Units) Table 162. Europe Opioid Receptor Agonist Sales Market Share Forecast by Country (2027-2032) Table 163. Europe Opioid Receptor Agonist Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 164. Europe Opioid Receptor Agonist Market Size by Country (2021-2026) & (US$ Million) Table 165. Europe Opioid Receptor Agonist Market Share by Country (2021-2026) Table 166. Europe Opioid Receptor Agonist Market Size Forecast by Country (2027-2032) & (US$ Million) Table 167. Europe Opioid Receptor Agonist Market Share Forecast by Country (2027-2032) Table 168. Asia-Pacific Opioid Receptor Agonist Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 169. Asia-Pacific Opioid Receptor Agonist Sales by Country (2021-2026) & (K Units) Table 170. Asia-Pacific Opioid Receptor Agonist Sales Market Share by Country (2021-2026) Table 171. Asia-Pacific Opioid Receptor Agonist Sales Forecast by Country (2027-2032) & (K Units) Table 172. Asia-Pacific Opioid Receptor Agonist Sales Market Share Forecast by Country (2027-2032) Table 173. Asia-Pacific Opioid Receptor Agonist Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 174. Asia-Pacific Opioid Receptor Agonist Market Size by Country (2021-2026) & (US$ Million) Table 175. Asia-Pacific Opioid Receptor Agonist Market Share by Country (2021-2026) Table 176. Asia-Pacific Opioid Receptor Agonist Market Size Forecast by Country (2027-2032) & (US$ Million) Table 177. Asia-Pacific Opioid Receptor Agonist Market Share Forecast by Country (2027-2032) Table 178. Latin America Opioid Receptor Agonist Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 179. Latin America Opioid Receptor Agonist Sales by Country (2021-2026) & (K Units) Table 180. Latin America Opioid Receptor Agonist Sales Market Share by Country (2021-2026) Table 181. Latin America Opioid Receptor Agonist Sales Forecast by Country (2027-2032) & (K Units) Table 182. Latin America Opioid Receptor Agonist Sales Market Share Forecast by Country (2027-2032) Table 183. Latin America Opioid Receptor Agonist Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 184. Latin America Opioid Receptor Agonist Market Size by Country (2021-2026) & (US$ Million) Table 185. Latin America Opioid Receptor Agonist Market Share by Country (2021-2026) Table 186. Latin America Opioid Receptor Agonist Market Size Forecast by Country (2027-2032) & (US$ Million) Table 187. Latin America Opioid Receptor Agonist Market Share Forecast by Country (2027-2032) Table 188. Middle East and Africa Opioid Receptor Agonist Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 189. Middle East and Africa Opioid Receptor Agonist Sales by Country (2021-2026) & (K Units) Table 190. Middle East and Africa Opioid Receptor Agonist Sales Market Share by Country (2021-2026) Table 191. Middle East and Africa Opioid Receptor Agonist Sales Forecast by Country (2027-2032) & (K Units) Table 192. Middle East and Africa Opioid Receptor Agonist Sales Market Share Forecast by Country (2027-2032) Table 193. Middle East and Africa Opioid Receptor Agonist Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 194. Middle East and Africa Opioid Receptor Agonist Market Size by Country (2021-2026) & (US$ Million) Table 195. Middle East and Africa Opioid Receptor Agonist Market Share by Country (2021-2026) Table 196. Middle East and Africa Opioid Receptor Agonist Market Size Forecast by Country (2027-2032) & (US$ Million) Table 197. Middle East and Africa Opioid Receptor Agonist Market Share Forecast by Country (2027-2032) Table 198. Key Raw Materials Table 199. Raw Materials Key Suppliers Table 200. Opioid Receptor Agonist Distributors List Table 201. Opioid Receptor Agonist Customers List Table 202. Research Programs/Design for This Report Table 203. Authors List of This Report Table 204. Secondary Sources Table 205. Primary Sources List of Figures Figure 1. Opioid Receptor Agonist Image Figure 2. Global Opioid Receptor Agonist Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Opioid Receptor Agonist Market Size (2021-2032) & (US$ Million) Figure 4. Global Opioid Receptor Agonist Sales (2021-2032) & (K Units) Figure 5. Morphine Image Figure 6. Global Morphine Sales YoY Growth (2021-2032) & (K Units) Figure 7. Codeine Image Figure 8. Global Codeine Sales YoY Growth (2021-2032) & (K Units) Figure 9. Fentanyl Image Figure 10. Global Fentanyl Sales YoY Growth (2021-2032) & (K Units) Figure 11. Others Image Figure 12. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 13. Global Opioid Receptor Agonist Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Opioid Receptor Agonist Market Share by Type 2025 VS 2032 Figure 15. North America Opioid Receptor Agonist Sales Market Share in Volume by Type in 2025 Figure 16. North America Opioid Receptor Agonist Sales Market Share in Value by Type in 2025 Figure 17. Europe Opioid Receptor Agonist Sales Market Share in Volume by Type in 2025 Figure 18. Europe Opioid Receptor Agonist Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Opioid Receptor Agonist Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Opioid Receptor Agonist Sales Market Share in Value by Type in 2025 Figure 21. Latin America Opioid Receptor Agonist Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Opioid Receptor Agonist Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Opioid Receptor Agonist Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Opioid Receptor Agonist Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Opioid Receptor Agonist Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Retail Pharmacy Image Figure 28. Global Retail Pharmacy Sales YoY Growth (2021-2032) & (K Units) Figure 29. Online Pharmacy Image Figure 30. Global Online Pharmacy Sales YoY Growth (2021-2032) & (K Units) Figure 31. Hospital Pharmacy Image Figure 32. Global Hospital Pharmacy Sales YoY Growth (2021-2032) & (K Units) Figure 33. Global Opioid Receptor Agonist Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Opioid Receptor Agonist Market Share by Application 2025 VS 2032 Figure 35. North America Opioid Receptor Agonist Sales Market Share in Volume by Application in 2025 Figure 36. North America Opioid Receptor Agonist Sales Market Share in Value by Application in 2025 Figure 37. Europe Opioid Receptor Agonist Sales Market Share in Volume by Application in 2025 Figure 38. Europe Opioid Receptor Agonist Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Opioid Receptor Agonist Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Opioid Receptor Agonist Sales Market Share in Value by Application in 2025 Figure 41. Latin America Opioid Receptor Agonist Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Opioid Receptor Agonist Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Opioid Receptor Agonist Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Opioid Receptor Agonist Sales Market Share in Value by Application in 2025 Figure 45. North America Opioid Receptor Agonist Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. North America Opioid Receptor Agonist Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Opioid Receptor Agonist Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Opioid Receptor Agonist Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Opioid Receptor Agonist Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Europe Opioid Receptor Agonist Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Opioid Receptor Agonist Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Opioid Receptor Agonist Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Opioid Receptor Agonist Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Asia-Pacific Opioid Receptor Agonist Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Opioid Receptor Agonist Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Opioid Receptor Agonist Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Opioid Receptor Agonist Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Latin America Opioid Receptor Agonist Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Opioid Receptor Agonist Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Opioid Receptor Agonist Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Opioid Receptor Agonist Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 62. Middle East and Africa Opioid Receptor Agonist Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Opioid Receptor Agonist Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Opioid Receptor Agonist Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Opioid Receptor Agonist Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Opioid Receptor Agonist Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Morphine
  • Codeine
  • Fentanyl
  • Others
Applications
  • Retail Pharmacy
  • Online Pharmacy
  • Hospital Pharmacy
Companies covered
  • Allergan
  • DAIICHI SANKYO COMPANY
  • Endo Pharmaceuticals
  • Fresenius Kabi
  • Hikma Pharmaceuticals
  • Indivior
  • Mylan N.V.
  • Piramal Critical Care
  • Purdue Pharma
  • Sun Pharmaceutical Industries
  • Tris Pharma
  • US WorldMeds
  • Pfizer
  • Johnson & Johnson
  • Teva Pharmaceutical Industries

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Opioid Receptor Agonist Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Opioid Receptor Agonist Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Opioid Receptor Agonist Market by Type
  6. 1.3.1 Morphine
  7. 1.3.2 Codeine
  8. 1.3.3 Fentanyl
  9. 1.3.4 Others
  10. 1.4 Global Opioid Receptor Agonist Market Size by Type
  11. 1.4.1 Global Opioid Receptor Agonist Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Opioid Receptor Agonist Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Opioid Receptor Agonist Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Opioid Receptor Agonist Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Opioid Receptor Agonist Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Opioid Receptor Agonist Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Opioid Receptor Agonist Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Opioid Receptor Agonist Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Opioid Receptor Agonist Industry Trends
  2. 2.2 Opioid Receptor Agonist Industry Drivers
  3. 2.3 Opioid Receptor Agonist Industry Opportunities and Challenges
  4. 2.4 Opioid Receptor Agonist Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Opioid Receptor Agonist Revenue (2021-2026)
  2. 3.2 Global Top Players by Opioid Receptor Agonist Sales (2021-2026)
  3. 3.3 Global Top Players by Opioid Receptor Agonist Price (2021-2026)
  4. 3.4 Global Opioid Receptor Agonist Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Opioid Receptor Agonist Major Company Production Sites & Headquarters
  6. 3.6 Global Opioid Receptor Agonist Company, Product Type & Application
  7. 3.7 Global Opioid Receptor Agonist Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Opioid Receptor Agonist Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Opioid Receptor Agonist Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Opioid Receptor Agonist Tier 1, Tier 2, and Tier 3
4 Opioid Receptor Agonist Regional Status and Outlook
  1. 4.1 Global Opioid Receptor Agonist Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Opioid Receptor Agonist Historic Market Size by Region
  3. 4.2.1 Global Opioid Receptor Agonist Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Opioid Receptor Agonist Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Opioid Receptor Agonist Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Opioid Receptor Agonist Forecasted Market Size by Region
  7. 4.3.1 Global Opioid Receptor Agonist Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Opioid Receptor Agonist Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Opioid Receptor Agonist Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Opioid Receptor Agonist by Application
  1. 5.1 Opioid Receptor Agonist Market by Application
  2. 5.1.1 Retail Pharmacy
  3. 5.1.2 Online Pharmacy
  4. 5.1.3 Hospital Pharmacy
  5. 5.2 Global Opioid Receptor Agonist Market Size by Application
  6. 5.2.1 Global Opioid Receptor Agonist Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Opioid Receptor Agonist Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Opioid Receptor Agonist Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Opioid Receptor Agonist Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Opioid Receptor Agonist Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Opioid Receptor Agonist Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Opioid Receptor Agonist Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Opioid Receptor Agonist Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Allergan
  2. 6.1.1 Allergan Company Information
  3. 6.1.2 Allergan Business Overview
  4. 6.1.3 Allergan Opioid Receptor Agonist Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Allergan Opioid Receptor Agonist Product Portfolio
  6. 6.1.5 Allergan Recent Developments
  7. 6.2 DAIICHI SANKYO COMPANY
  8. 6.2.1 DAIICHI SANKYO COMPANY Company Information
  9. 6.2.2 DAIICHI SANKYO COMPANY Business Overview
  10. 6.2.3 DAIICHI SANKYO COMPANY Opioid Receptor Agonist Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 DAIICHI SANKYO COMPANY Opioid Receptor Agonist Product Portfolio
  12. 6.2.5 DAIICHI SANKYO COMPANY Recent Developments
  13. 6.3 Endo Pharmaceuticals
  14. 6.3.1 Endo Pharmaceuticals Company Information
  15. 6.3.2 Endo Pharmaceuticals Business Overview
  16. 6.3.3 Endo Pharmaceuticals Opioid Receptor Agonist Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Endo Pharmaceuticals Opioid Receptor Agonist Product Portfolio
  18. 6.3.5 Endo Pharmaceuticals Recent Developments
  19. 6.4 Fresenius Kabi
  20. 6.4.1 Fresenius Kabi Company Information
  21. 6.4.2 Fresenius Kabi Business Overview
  22. 6.4.3 Fresenius Kabi Opioid Receptor Agonist Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Fresenius Kabi Opioid Receptor Agonist Product Portfolio
  24. 6.4.5 Fresenius Kabi Recent Developments
  25. 6.5 Hikma Pharmaceuticals
  26. 6.5.1 Hikma Pharmaceuticals Company Information
  27. 6.5.2 Hikma Pharmaceuticals Business Overview
  28. 6.5.3 Hikma Pharmaceuticals Opioid Receptor Agonist Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Hikma Pharmaceuticals Opioid Receptor Agonist Product Portfolio
  30. 6.5.5 Hikma Pharmaceuticals Recent Developments
  31. 6.6 Indivior
  32. 6.6.1 Indivior Company Information
  33. 6.6.2 Indivior Business Overview
  34. 6.6.3 Indivior Opioid Receptor Agonist Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Indivior Opioid Receptor Agonist Product Portfolio
  36. 6.6.5 Indivior Recent Developments
  37. 6.7 Mylan N.V.
  38. 6.7.1 Mylan N.V. Company Information
  39. 6.7.2 Mylan N.V. Business Overview
  40. 6.7.3 Mylan N.V. Opioid Receptor Agonist Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Mylan N.V. Opioid Receptor Agonist Product Portfolio
  42. 6.7.5 Mylan N.V. Recent Developments
  43. 6.8 Piramal Critical Care
  44. 6.8.1 Piramal Critical Care Company Information
  45. 6.8.2 Piramal Critical Care Business Overview
  46. 6.8.3 Piramal Critical Care Opioid Receptor Agonist Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Piramal Critical Care Opioid Receptor Agonist Product Portfolio
  48. 6.8.5 Piramal Critical Care Recent Developments
  49. 6.9 Purdue Pharma
  50. 6.9.1 Purdue Pharma Company Information
  51. 6.9.2 Purdue Pharma Business Overview
  52. 6.9.3 Purdue Pharma Opioid Receptor Agonist Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Purdue Pharma Opioid Receptor Agonist Product Portfolio
  54. 6.9.5 Purdue Pharma Recent Developments
  55. 6.10 Sun Pharmaceutical Industries
  56. 6.10.1 Sun Pharmaceutical Industries Company Information
  57. 6.10.2 Sun Pharmaceutical Industries Business Overview
  58. 6.10.3 Sun Pharmaceutical Industries Opioid Receptor Agonist Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Sun Pharmaceutical Industries Opioid Receptor Agonist Product Portfolio
  60. 6.10.5 Sun Pharmaceutical Industries Recent Developments
  61. 6.11 Tris Pharma
  62. 6.11.1 Tris Pharma Company Information
  63. 6.11.2 Tris Pharma Business Overview
  64. 6.11.3 Tris Pharma Opioid Receptor Agonist Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Tris Pharma Opioid Receptor Agonist Product Portfolio
  66. 6.11.5 Tris Pharma Recent Developments
  67. 6.12 US WorldMeds
  68. 6.12.1 US WorldMeds Company Information
  69. 6.12.2 US WorldMeds Business Overview
  70. 6.12.3 US WorldMeds Opioid Receptor Agonist Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 US WorldMeds Opioid Receptor Agonist Product Portfolio
  72. 6.12.5 US WorldMeds Recent Developments
  73. 6.13 Pfizer
  74. 6.13.1 Pfizer Company Information
  75. 6.13.2 Pfizer Business Overview
  76. 6.13.3 Pfizer Opioid Receptor Agonist Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Pfizer Opioid Receptor Agonist Product Portfolio
  78. 6.13.5 Pfizer Recent Developments
  79. 6.14 Johnson & Johnson
  80. 6.14.1 Johnson & Johnson Company Information
  81. 6.14.2 Johnson & Johnson Business Overview
  82. 6.14.3 Johnson & Johnson Opioid Receptor Agonist Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Johnson & Johnson Opioid Receptor Agonist Product Portfolio
  84. 6.14.5 Johnson & Johnson Recent Developments
  85. 6.15 Teva Pharmaceutical Industries
  86. 6.15.1 Teva Pharmaceutical Industries Company Information
  87. 6.15.2 Teva Pharmaceutical Industries Business Overview
  88. 6.15.3 Teva Pharmaceutical Industries Opioid Receptor Agonist Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Teva Pharmaceutical Industries Opioid Receptor Agonist Product Portfolio
  90. 6.15.5 Teva Pharmaceutical Industries Recent Developments
7 North America by Country
  1. 7.1 North America Opioid Receptor Agonist Sales by Country
  2. 7.1.1 North America Opioid Receptor Agonist Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Opioid Receptor Agonist Sales by Country (2021-2026)
  4. 7.1.3 North America Opioid Receptor Agonist Sales Forecast by Country (2027-2032)
  5. 7.2 North America Opioid Receptor Agonist Market Size by Country
  6. 7.2.1 North America Opioid Receptor Agonist Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Opioid Receptor Agonist Market Size by Country (2021-2026)
  8. 7.2.3 North America Opioid Receptor Agonist Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Opioid Receptor Agonist Sales by Country
  2. 8.1.1 Europe Opioid Receptor Agonist Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Opioid Receptor Agonist Sales by Country (2021-2026)
  4. 8.1.3 Europe Opioid Receptor Agonist Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Opioid Receptor Agonist Market Size by Country
  6. 8.2.1 Europe Opioid Receptor Agonist Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Opioid Receptor Agonist Market Size by Country (2021-2026)
  8. 8.2.3 Europe Opioid Receptor Agonist Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Opioid Receptor Agonist Sales by Country
  2. 9.1.1 Asia-Pacific Opioid Receptor Agonist Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Opioid Receptor Agonist Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Opioid Receptor Agonist Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Opioid Receptor Agonist Market Size by Country
  6. 9.2.1 Asia-Pacific Opioid Receptor Agonist Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Opioid Receptor Agonist Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Opioid Receptor Agonist Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Opioid Receptor Agonist Sales by Country
  2. 10.1.1 South America Opioid Receptor Agonist Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Opioid Receptor Agonist Sales by Country (2021-2026)
  4. 10.1.3 South America Opioid Receptor Agonist Sales Forecast by Country (2027-2032)
  5. 10.2 South America Opioid Receptor Agonist Market Size by Country
  6. 10.2.1 South America Opioid Receptor Agonist Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Opioid Receptor Agonist Market Size by Country (2021-2026)
  8. 10.2.3 South America Opioid Receptor Agonist Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Opioid Receptor Agonist Sales by Country
  2. 11.1.1 Middle East and Africa Opioid Receptor Agonist Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Opioid Receptor Agonist Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Opioid Receptor Agonist Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Opioid Receptor Agonist Market Size by Country
  6. 11.2.1 Middle East and Africa Opioid Receptor Agonist Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Opioid Receptor Agonist Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Opioid Receptor Agonist Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Opioid Receptor Agonist Value Chain Analysis
  2. 12.1.1 Opioid Receptor Agonist Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Opioid Receptor Agonist Production Mode & Process
  7. 12.2 Opioid Receptor Agonist Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Opioid Receptor Agonist Distributors
  10. 12.2.3 Opioid Receptor Agonist Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst